Novel esculetin derivatives and pharmaceutical composition

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/18 (2006.01) A61K 31/37 (2006.01) C07D 311/16 (2006.01)

Patent

CA 2116617

A pharmaceutical composition comprising a compound of the general formula (I): (see formula I) wherein R1 and R2 are, independently, a hydrogen atom, a saturated or unsaturated aliphatic acyl having 2 to 25 carbon atoms or benzoyl group and R3 is a hydrogen atom or alkyl group, and a pharmaceutically acceptable carrier is disclosed. Further, a novel compound of the general formula (I) wherein R1 and R2 are, independently, a hydrogen atom, pivaloyl, capryloyl, lauroyl, palmitoyl, stearoyl, linoleoyl, docosahexaenoyl, or benzoyl group, and R3 is a hydrogen atom or methyl group, is also disclosed. The pharmaceutical composition is useful as a chondroprotective agent for prohibiting the destruction of,articular cartilage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel esculetin derivatives and pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel esculetin derivatives and pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel esculetin derivatives and pharmaceutical composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1435478

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.